Colorectal cancer in 2014: Progress in defining first-line and maintenance therapies

@article{Hubbard2015ColorectalCI,
  title={Colorectal cancer in 2014: Progress in defining first-line and maintenance therapies},
  author={Joleen M Hubbard and Axel F Grothey},
  journal={Nature Reviews Clinical Oncology},
  year={2015},
  volume={12},
  pages={73-74}
}
The results of several clinical trials in metastatic colorectal cancer presented in 2014 will influence clinical practice. These findings include definitive data from phase III trials comparing bevacizumab and cetuximab-based therapy in the first-line, studies elucidating the value of maintenance therapy after induction treatment, and data on new agents in… CONTINUE READING